Mesoblast | MSB - Ordinary Share Capital


Mesoblast reported $1.3B in Ordinary Share Capital for its fiscal semester ending in June of 2026.





Ordinary Share Capital Change Date
Clinuvel Pharmaceuticals AUD 50.2M 77.11K Dec/2025
Cochlear AUD 65.4M 1.12B Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Pacific Edge NZD 1.02B 497K Jun/2026
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Telix Pharmaceuticals AUD 339.78M 1.01M Jun/2026